Study of an Interposition Supraciliary Implant in Patients With Open Angle Glaucoma (SAFARI FU)

Ciliatech

Status: Active, not recruiting

Conditions: Glaucoma, Open-Angle

Study type: Observational

Funder types: Industry

Identifiers

NCT05159817

SAFARI FU

Details and patient eligibility

About

The purpose of this study is to prolong observational follow-up up to 36 months of patients already implanted with a novel interposition supraciliary implant.

Full description

19 patients with primary open angle glaucoma (POAG) refractory to topical medical therapy were operated in late 2020 and a novel interposition supraciliary device implanted.

These patients reached 6 months follow-up and the original study had to be interrupted.

This observational study prolonges follow-up to 36 months

Enrollment: 19 patients

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients who were implanted in this center with the novel supraciliary interposition device under the scope of clinical trial NCT03736655

Exclusion criteria

• if cannot assist to all future follow-up visits